The effectiveness of mRNA vaccines in reducing disease severity and hospitalization from COVID-19 is well established. Now, new research from the University of Wisconsin School of Veterinary Medicine advances our understanding of how these vaccines protect the lungs following breakthrough infections from emerging variants of...
Researchers at the University of Wisconsin School of Medicine and Public Health are investigating how well the updated monovalent COVID-19 vaccines work for inflammatory bowel disease patients....
Vaccines for heart disease and cancer could help combat these diseases and advance researchers' understanding of the human body, but are they the magic cure-all many expect them to be?...
Patients and those with affected family or community members have joined researchers, clinicians, and experts in their efforts to unlock the mysteries of Long COVID....
Decentralized clinical trials rose in prominence during the COVID-19 pandemic. Are they here to stay?...
Scientists have unveiled a road map for the development of a new vaccine that would be broadly protective against all coronaviruses....
National Institutes of Health (NIH) representatives state that international investment, collaboration, and coordination have been key to responding to the COVID-19 pandemic....
The COVID-19 pandemic radically changed our perspectives on how to conduct research and clinical care, and it set the stage for data-driven biomedical research and clinical practice....
The pre-pandemic environment for clinical trials has been described as unsustainable by many observers, so the massive disruption caused by COVID-19 also presents ripe opportunities for improvement....
SMPH faculty members share their experiences related to the novel coronavirus and its ramifications on individuals, families and communities....
